Pathologic Assessment of Melanoma Sentinel Nodes: A Role for Molecular Analysis Using Quantitative Real-Time Reverse Transcription-PCR for MART-1 and Tyrosinase Messenger RNA
Open Access
- 15 February 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 11 (4) , 1425-1433
- https://doi.org/10.1158/1078-0432.ccr-04-1193
Abstract
Purpose: Molecular analysis of melanoma sentinel nodes (SN) is sensitive, but poorly specific because metastases cannot be distinguished from benign nevus inclusions (BNI). We investigated whether quantitative reverse transcription-PCR (RT-PCR) detection of MART-1 and tyrosinase mRNAs could improve this specificity and contribute to SN assessment.Keywords
This publication has 37 references indexed in Scilit:
- Quantification of Melanoma mRNA Markers in Sentinel Nodes: Pre-Clinical Evaluation of a Single-Step Real-Time Reverse Transcriptase-Polymerase Chain Reaction AssayThe Journal of Molecular Diagnostics, 2004
- Sentinel lymph nodes in malignant melanomaCancer, 2004
- Prediction of Disease Outcome in Melanoma Patients by Molecular Analysis of Paraffin-Embedded Sentinel Lymph NodesJournal of Clinical Oncology, 2003
- Lymphatic Mapping and Sentinel Lymphadenectomy for Early-Stage MelanomaAnnals of Surgery, 2003
- Detection of micrometastases in sentinel lymph nodes from melanoma patientsMelanoma Research, 2003
- Prognostic Significance of Reverse Transcriptase-Polymerase Chain Reaction?Negative Sentinel Nodes in Malignant MelanomaAnnals of Surgical Oncology, 2003
- Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsyBritish Journal of Surgery, 2002
- Examination of Regional Lymph Nodes by Sentinel Node Biopsy and Molecular Analysis Provides New Staging Facilities in Primary Cutaneous MelanomaJournal of Investigative Dermatology, 2000
- Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trialThe Lancet, 1998
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992